Andreas Wallnöfer joined BioMedPartners as a new Partner in 2016. He is a senior executive leader with more than 20 years’ experience in the pharmaceutical industry, including 12 years as a member of the F. Hoffmann-La Roche Pharma R&D Leadership and Portfolio Committee. He led the Roche Pharma Cardiovascular & Metabolism Disease Area and left Roche in 2015 after the company strategically decided to exit these research areas.
At Roche he was involved in several successful product development programs. As Head of Clinical Research & Exploratory Development Andreas and his groups were involved in the Due Diligence evaluations for in-licensing projects and product acquisitions. He also played a key role in the integration of the Roche and Genentech Development organisations and subsequently led Early Development and Portfolio Management at Roche.
Andreas has a PhD in Pharmacology from the University of Basel, Switzerland and trained as a fellow in Clinical Pharmacology at the University of Leiden, the Netherlands. He holds a Master of Technology Enterprise and an Executive MBA from IMD Lausanne, Switzerland.